Christopher J. Lord

9 articles listing Christopher J. Lord in Nature Communications, Nature, indexed by Paperzzz from Crossref and OSF.

1. The anion channel GPR89 is a tumor-specific dependency in breast cancer Nature Communications
2. Two decades of PARP inhibitor synthetic lethality in cancer Nature
3. Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors Nature Communications
4. NASP modulates histone turnover to drive PARP inhibitor resistance Nature
5. Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial Nature Communications
6. Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers Nature Communications
7. Author Correction: Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion Nature Communications
8. The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models Nature Communications
9. Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion Nature Communications